China · Delayed Price · Currency is CNY Porton Pharma Solutions Statistics
Total Valuation
SHE:300363 has a market cap or net worth of CNY 11.22 billion. The enterprise value is 11.30 billion.
| Market Cap | 11.22B |
| Enterprise Value | 11.30B |
Important Dates
The last earnings date was Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | May 12, 2026 |
Share Statistics
SHE:300363 has 536.27 million shares outstanding. The number of shares has increased by 0.20% in one year.
| Current Share Class | 536.27M |
| Shares Outstanding | 536.27M |
| Shares Change (YoY) | +0.20% |
| Shares Change (QoQ) | -5.21% |
| Owned by Insiders (%) | 27.14% |
| Owned by Institutions (%) | 16.09% |
| Float | 311.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 56.57 |
| PS Ratio | 3.08 |
| PB Ratio | 2.18 |
| P/TBV Ratio | 2.49 |
| P/FCF Ratio | 15.44 |
| P/OCF Ratio | 13.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.92, with an EV/FCF ratio of 15.54.
| EV / Earnings | n/a |
| EV / Sales | 3.10 |
| EV / EBITDA | 15.92 |
| EV / EBIT | 41.75 |
| EV / FCF | 15.54 |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.25.
| Current Ratio | 2.01 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.72 |
| Debt / FCF | 1.74 |
| Interest Coverage | 35.37 |
Financial Efficiency
Return on equity (ROE) is -2.84% and return on invested capital (ROIC) is 5.62%.
| Return on Equity (ROE) | -2.84% |
| Return on Assets (ROA) | 2.16% |
| Return on Invested Capital (ROIC) | 5.62% |
| Return on Capital Employed (ROCE) | 4.53% |
| Weighted Average Cost of Capital (WACC) | 6.57% |
| Revenue Per Employee | 827,295 |
| Profits Per Employee | -21,755 |
| Employee Count | 4,400 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.99 |
Taxes
In the past 12 months, SHE:300363 has paid 70.32 million in taxes.
| Income Tax | 70.32M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.34% in the last 52 weeks. The beta is 0.55, so SHE:300363's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -18.34% |
| 50-Day Moving Average | 21.73 |
| 200-Day Moving Average | 20.42 |
| Relative Strength Index (RSI) | 43.23 |
| Average Volume (20 Days) | 16,776,961 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300363 had revenue of CNY 3.64 billion and -95.72 million in losses. Loss per share was -0.18.
| Revenue | 3.64B |
| Gross Profit | 1.19B |
| Operating Income | 286.59M |
| Pretax Income | -80.91M |
| Net Income | -95.72M |
| EBITDA | 658.53M |
| EBIT | 286.59M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 1.29 billion in cash and 1.26 billion in debt, with a net cash position of 27.03 million or 0.05 per share.
| Cash & Cash Equivalents | 1.29B |
| Total Debt | 1.26B |
| Net Cash | 27.03M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 5.15B |
| Book Value Per Share | 9.93 |
| Working Capital | 1.70B |
Cash Flow
In the last 12 months, operating cash flow was 842.07 million and capital expenditures -114.96 million, giving a free cash flow of 727.11 million.
| Operating Cash Flow | 842.07M |
| Capital Expenditures | -114.96M |
| Depreciation & Amortization | 371.94M |
| Net Borrowing | -497.56M |
| Free Cash Flow | 727.11M |
| FCF Per Share | 1.36 |
Margins
Gross margin is 32.65%, with operating and profit margins of 7.87% and -2.63%.
| Gross Margin | 32.65% |
| Operating Margin | 7.87% |
| Pretax Margin | -2.22% |
| Profit Margin | -2.63% |
| EBITDA Margin | 18.09% |
| EBIT Margin | 7.87% |
| FCF Margin | 19.98% |
Dividends & Yields
This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 0.43%.
| Dividend Per Share | 0.09 |
| Dividend Yield | 0.43% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 6.88% |
| Buyback Yield | -0.20% |
| Shareholder Yield | 0.23% |
| Earnings Yield | -0.85% |
| FCF Yield | 6.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 29, 2015. It was a forward split with a ratio of 1.5.
| Last Split Date | Sep 29, 2015 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |